EGFR and prostate carcinoma: Our results suggest that, in prostate cancer, increase in clathrin expression is associated with an increased colocalization with EGFR (Fig. 6), indicating EGFR recycling may allow cancer to progress through a constitutive proliferative signaling mechanism.